trump-person-of-the-year-time-dec-2016Based on a TIME magazine interview conducted today with President-Elect Donald Trump, the pharmaceutical and life science industries may expect to find coal in their Christmas stocking, and tougher pricing constraints in 2017.

“I’m going to bring down drug prices,” Mr. Trump said, quoted on the TIME website naming him Person of the Year. “I don’t like what’s happened with drug prices.”

As CNN put it, “Trump put the entire drug industry on notice on Wednesday in an interview with Time.”

In fact, Donald Trump’s campaign website talked about drug importation as one potential tactic consumers could potentially use to bring down their household prescription drug costs.

Media coverage of the interview’s pharma content appeared in many business and trade publications, among them:

  • Bloomberg, Trump’s Vow to Control Drug Costs Alerts Another Industry, which titled their short video, “Trump: Bad Medicine for Pharma?”
  • Money magazine quoted Trump saying, “I will bring down drug prices.”
  • The UK Daily Mail wrote, “Trump vows to bring down drug prices, doesn’t say how.”
  • Barron’s acknowledged that, “Trump Comments on Drug Prices Sink Biotech.” Among stocks that took price hits on 7 December following the TIME comments were Incyte, Celgene, both down 5%; Vertex, Illumina, Mylan, and Regeneron, down 4%. The SPDR S&P Pharmaceutical ETF fell 3.4%, and iShares NASDAQ Bioetch ETF was down 4.2% at one point on the day.
  • Seeking Alpha‘s DoctoRx (a Health Populi favorite commentator), coined, “Et tu, Donald? Drugs Dive: What’s Going On, And What’s Next. DoctoRx reminded us that, “This should be no surprise to anyone. Mr. Trump’s campaign website was rudimentary for quite a long time, but one of the points it specified early was that he would work to equalize drug prices between the US and other developed countries.”

spike-in-prescription-drug-prices-in-us-vs-medical-inflation-bmi-webinar-12-7-16Health Populi’s Hot Points:  Check out the link graph, which illustrates prescription drug price inflation fluctuations compared with medical care and general consumer price inflation (sourced from the U.S. Bureau of Labor Statistics).

Note the dark blue line, which for the past two years has generally been above (and sometimes, well above) health care inflation and always above general market basket issues over the two years since May 2014.

The issue of drug pricing hit popular culture status in 2016 based on the EpiPen pricing story, on top of the past two years’ stories of Gilead’s Hepatitis C drug pricing (for Harvoni and Sovaldi), and the demonization of Martin Shkreli of Turing Phpeople-magazine-and-epipen-sept-2016-croppedarmaceuticals, called, “The Bad Boy of Pharma” by the New York Times one year ago.

Note the September 12, 2016, People magazine coverage (pictured in “Passages” image) of the EpiPen, which I noted inside the issue featuring Rob Kardashian’s impending fatherhood.

From an investment standpoint, DoctoRx of Seeking Alpha recommends investors take a long view looking at industry fundamentals and the fact that it’s hard to cut health benefits. But in this new-new era of President Trump, what’s past is not prologue. I’m expecting public support of more stringent drug pricing regimes moving closer to European nations’ constraints and value-based evaluations using health economics outcomes research (HEOR).

 

11 Comments on You Better Watch Out, You Better Not Cry, Pharma: Donald Trump is Coming to Town

HealthPopuli.com said : Guest Report 6 months ago

[…] A key health care cost focus of Congress will target prescription drug costs. Expect pharmaceutical companies to raise prices in 2019 — “with a wink to Trump,” Bloomberg News characterized last week — prompting Congressional health care activists (particularly Democrats in the House) to come together on legislation and collaborate with President Trump on this issue which he promised would be a priority when he took office. […]

HealthPopuli.com said : Guest Report 9 months ago

[…] Remember that President Trump promised American voters in his TIME magazine Person of the Year interview in December 2016 that he would drive down Rx costs for consumers — because, as he has often said, “Drug companies are getting away with murder” in terms of pricing.  [Here’s my take on the TIME interview in Health Populi]. […]

HealthPopuli.com said : Guest Report one year ago

[…] Trump campaigned on this issue and was quoted in his TIME magazine “Person of the Year” profile saying, “we have to…create new bidding procedures for the drug industry, because […]

HealthPopuli.com said : Guest Report one year ago

[…] Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure. We […]

Decline in Pharmacy Reputations Related to Prescription Drug Prices, J.D. Power Finds – Tithe Guerrero's Blog said : Guest Report 2 years ago

[…] fact, in Donald Trump’s interview as TIME Magazine Man of the Year in December 2016, he told TIME: “I’m going to bring down drug prices. I don’t like what’s […]

HealthPopuli.com said : Guest Report 2 years ago

[…] fact, in Donald Trump’s interview as TIME Magazine Man of the Year in December 2016, he told TIME: “I’m going to bring down drug prices. I don’t like what’s […]

Global Drug Sales Forecasts Fall For Next Five Years – Tithe Guerrero's Blog said : Guest Report 2 years ago

[…] or as aggressively by the White House as President Trump had committed during his campaign. Remember Candidate Trump’s pronouncement — “I’m going to bring down drug prices,” Mr. Trump said, quoted on the TIME website […]

HealthPopuli.com said : Guest Report 2 years ago

[…] or as aggressively by the White House as President Trump had committed during his campaign. Remember Candidate Trump’s pronouncement — “I’m going to bring down drug prices,” Mr. Trump said, quoted on the TIME website […]

HealthPopuli.com said : Guest Report 2 years ago

[…] away with murder,” as President Trump said in a TIME magazine interview which I profiled here in Health Populi in December […]

HealthPopuli.com said : Guest Report 2 years ago

[…] message. The President didn’t use the “M” word in this meeting as he did in his interview as TIME magazine’s Person of the Year, claiming these same companies were committing “murder” due to their Rx pricing […]

Leave a Reply

Your email address will not be published. Required fields are marked